facebook
twitter
rss
account
search
search
 

Vaccine for methamphetamine promising

Sept. 17, 2011 at 12:55 PM   |   Comments

LA JOLLA, Calif., Sept. 17 (UPI) -- Three promising formulations could be used in a vaccine to treat methamphetamine addiction, U.S. researchers say.

Kim Janda of the Scripps Research Institute in La Jolla, Calif., and colleagues note methamphetamine use and addiction cost the United States more than $23 billion annually due to medical and law enforcement expenses, as well as lost productivity.

The highly addictive crystal meth can cause a variety of problems including cardiovascular damage and death.

The study, published in the Journal of the American Chemical Society, found three of the new formulations that produced a good immune response in mice were particularly promising.

These findings represent a unique approach to the design of new vaccines against methamphetamine abuse, Janda says.

Previously tested meth vaccines either are not effective or are very expensive.

© 2011 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Featured UPI Collection
trending
Notable deaths of 2014 [PHOTOS]

Notable deaths of 2014 [PHOTOS]

Most Popular
1
New research explains insomnia prevalence among elderly
2
New data shows Melbourne is most well-rested city in the world
3
New research details rare cancer that killed Bob Marley
4
Daughters more likely than sons to care for elder parents
5
Yoga guru BKS Iyengar dies at 95
Trending News
Video
x
Feedback